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ABSTRACT

Integrated primary care assimilates psychologists into the primary care setting, thus
improving health outcomes and physician satisfaction. Neuropsychology has also begun to
assimilate into primary care, as neurocognitive impairment is a correlate of many medical
disorders. Subjective cognitive decline (SCD), a common complaint among older adults, is an
increasingly recognized warning sign of non-normative cognitive aging. These patients typically
present first to their primary care providers who may play a critical role in the early detection of
cognitive impairment. Given the growing awareness about cognitive health and disability, the
importance of neuropsychological assessment as a standard component of integrated care has
been recognized by providers. Thus, the purpose of this study is to examine the efficacy and
feasibility of neuropsychological services, for memory concerns, in a community primary care
setting. The study also explored the relationship between SCD and performance on
neurocognitive measures and satisfaction levels for both patient participants and medical
providers. A total of 16 patient participants completed the study. On average, patients were in
their late-60’s and mostly female and Caucasian. Participants completed a brief interview,
neurocognitive evaluation, self-report measures of SCD and mood, and satisfaction survey.
Results did not reveal significant correlations between SCD and neurocognitive performance.
Significantly more referrals were made to the onsite neurocognitive clinic, than were made for
outside services in a nine-month period preceding the described program. Patients referred to the
onsite clinic were also significantly more likely to have an accessible report located in their EMR
than those referred offsite. Both participants and medical providers were reportedly satisfied with
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clinic services. Results suggest that a clinic of this nature has promising benefits and is wellliked by both patients and providers, though barriers related to full utilization of services remain
a challenge. Further research with a larger, more diverse sample is recommended.
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CHAPTER 1: INTRODUCTION

Integrated Primary Care (IPC) assimilates psychologists into the primary care setting to
collaborate and work alongside primary care providers (James, 2006). Traditionally, primary
care refers to the provision of integrated and accessible health care services by providers who
address a large majority of personal health care needs, develop a sustained partnership with
patients, and practice in the context of family and community. Behavioral health typically refers
to the broad area of mental health and substance abuse conditions as well as health behaviors
(including their influence to chronic medical illnesses), life stressors, and physical symptoms
related to stress. Therefore, primary care and behavioral health integration is defined as “the care
that results from a practice team of primary care and behavioral health clinicians, working
together with patients and families, using a systematic and cost-effective approach to provide
patient-centered care for a defined population,” (Peek, 2013; Vogel, Kanzler, Aikens, & Goodie,
2017). While IPC is a relatively new field of practice, it is constantly evolving to adapt to the
needs of the patient-centered medical home. Given its early stages, research in IPC remains
limited; however, current research has explored common referral questions related to depression,
anxiety, and Attention-Deficit/Hyperactivity Disorder (Craig, 2015), and more recently, the role
of neuropsychological assessment in primary care (Kubu, Ready, Festa, Roper, & Pliskin, 2016;
Michels, Tiu, & Graver, 2010).
Changes in an individual’s cognitive abilities can be seen across the lifespan. Broadly,
cognitive abilities decline between one and two standard deviations between twenty and seventy
years of age (Anstey & Low, 2004; Salthouse, 2009, 2012). The extent of age-associated
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cognitive decline differs among individuals and can generally be delineated into normative, or
non-pathological cognitive aging, and pathological cognitive aging (Deary & Der, 2005; Park,
Polk, Mikels, Taylor, & Marshuetz, 2001; Raz et al., 2005). However, individual trajectories of
cognitive aging can vary widely and are affected by numerous lifestyle and idiographic factors
including components such as diet, neurobiological changes, genetics, overall general health,
cerebrovascular factors such as atherosclerotic disease, and biological processes such as
inflammation, and other medical factors (Deary et al., 2009). Clinical neuropsychology has
emerged as one strategy to characterize the broad heterogeneity in the presentation, etiology, and
prognosis of cognitive impairment in clinical populations of older adults.

Clinical Neuropsychology
Clinical neuropsychology is an “applied science concerned with the behavioral
expression of brain dysfunction” (Lezak, 2004, p. 7). In addition, the National Academy of
Neuropsychology’s (NAN) definition of a clinical neuropsychologist, stipulates that a clinical
neuropsychologist possesses expertise in brain–behavior relationships (Barth et al., 2003).
Clinical neuropsychologists use this knowledge in the assessment, diagnosis, treatment, and
rehabilitation of individuals with neurological, medical, or neurodevelopmental conditions, as
well as other cognitive and learning disorders (Barth et al., 2003; Lezak, 2004). In order to
evaluate an individual’s neurocognitive strengths and weaknesses, as well as components of
emotional and behavioral functioning, neuropsychological assessment utilizes a combination of
psychological, neurological, cognitive, behavioral, and physiological tests. An individual’s
performance is then compared to others of similar age, gender, and education level to better

2

understand the relationship to normal and abnormal cognitive and/or central nervous system
functioning (Barth et al., 2003; Lezak, 2004).
The goals and benefits associated with neuropsychological assessment may differ as a result
of the referral question. For example, the goal of establishing probable localization,
lateralization, and etiology of a brain lesion may be best suited to aid with surgical interventions
for epilepsy surgery or deep brain stimulation, whereas identifying an individual’s
neuropsychological and neurobehavioral profile may most aid in distinguishing between normal
cognitive aging and atypical cognitive aging or between varieties of dementia (Lezak, 2004;
Michels et al., 2010). Broadly speaking, though, neuropsychologists assess brain function and
impairment by drawing inferences from performance on objective test measures. Tests that
examine neuropsychological functioning are often able to identify subtle cognitive deficits that
may not be detected by electro-physiological or imaging methods. Performance on these
assessment measures are subsequently used to inform clinical decision making, planning, and
monitoring the outcomes and effects of treatment (Lezak, 2004; Michels et al., 2010).
Additionally, the assessment of an individual’s cognitive capacities and potential deficits aids in
elucidating real-world resources and limitations. Neuropsychological services may also function
to improve an individual’s overall quality of life through cognitive rehabilitation (cognitive
skills, judgment, and decision making). A review of the literature has demonstrated benefit in
treating these deficits among stoke and traumatic brain injury (TBI) (Cicerone et al., 2005;
Stephens, Williamson, & Berryhill, 2015)
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Integrated Primary Care
As noted above, IPC works to assimilate psychologists into the primary care setting, so
that they are better able to collaborate and work alongside primary care providers (James, 2006).
Integrated primary care and its subsequent benefits have been illustrated with a five-component
model that includes components of collaboration, access to care, satisfaction, quality treatment,
and reduced costs (James & O’Donohue, 2009).
Collaboration. Integrated primary care aims to create an environment that is conducive to
collaboration of providers. This collaboration is fostered by co-locating primary care and mental
health in the same facility, as well as encouraging an integrated treatment approach (James,
2006; James & O’Donohue, 2009). The aim of IPC treatment is to develop one comprehensive
treatment plan in which providers contribute their area of expertise (A. Blount, 2003). The
emphasis on collaboration in IPC is in accordance with the movement towards a patient-centered
medical home (PCMH) as supported by The Agency for Healthcare Research and Quality. Both
IPC, as well as a PCMH intends to provide comprehensive, coordinated, and quality patientcentered care. IPC also minimizes lack of communication between medical and mental health
providers as they utilize the same location and medical record systems (Peikes, Zutshi, Genevro,
Parchman, & Meyers, 2012).
Access to care. Approximately 25% of adults visiting their PCP have a psychiatric
disorder, and yet close to half of these cases go undetected (Roy-Byrne & Wagner, 2004). Onsite
behavioral health providers can aid in improving detection rates and implementing prevention
and early intervention. Integrating mental health services into the medical home, may reduce the
stigma associated with mental health and thus, patients may be more receptive to services (Craig,
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2015). IPC can also help identify and treat populations experiencing mental health problems that
may not otherwise seek or receive treatment. In traditional primary care settings, about 40% of
patients are referred to specialty mental health, with only 10% of those individuals attending
their first appointment (LaBrie et al., 2007). Whereas, an integrated primary care psychologist
can increase access and follow-through rate, such that, of the roughly 70% of patients referred to
attend behavioral health treatment, about 54% attend their first appointment (Miller-Matero et
al., 2015).
Satisfaction. Several studies have demonstrated increased satisfaction ratings among both
patients and providers within an integrated primary care setting (Chen et al., 2006; Farrar, Kates,
Crustolo, & Nikolaou, 2001). Past research has indicated that while physicians recognized the
need for addressing the emotional well-being of patients, they also reported encountering
difficulties with the referral process, as a result of the stigma often associated with psychiatry as
well as lack of follow-through by patients (James, 2006; Morgan & Killoughery, 2003). A recent
survey of family physicians found that those who had access to mental health services onsite
reported a higher level of satisfaction and also identified increased communication,
collaboration, and access to treatment as benefits of having mental health providers onsite
(Kates, Fugere, & Farrar, 2004). Further, it has also been documented that providers feel an
increased sense of comfort and confidence when assessing patient’s needs with regard to mental
health, substance use, and suicide risk when having onsite behavioral health specialists with
whom they may consult and collaborate (F. A. Blount & Miller, 2009).
Quality of Treatment. Quality of delivery of healthcare is improved in IPC by also addressing
mental health problems, which have been established to be risk factors for many physical health
5

problems (Prince et al., 2007). With regard to attending to mental health concerns, quality of
patient care may be diminished as the process of referring and coordination between medical and
mental health professionals can often be lengthy, causing aspects of professional and patient
communication, as well as the referral itself, to be left incomplete. Behavioral health specialists
can enhance patient care by assisting patients in implementing lifestyle and behavioral changes,
including those recommended by their medical providers, to promote better management of
chronic conditions and overall health (Miller, Mendenhall, & Malik, 2009). Further, consultation
and collaboration among treatment providers under one treatment plan, as opposed to segregated
care plans, aids in improving quality of care. Research demonstrates improved treatment
outcomes, including decreased symptomatology, in integrated care systems as compared to
traditional primary care systems (Hedrick et al., 2003; Zeiss & Karlin, 2008).
Reduced costs. Collectively, depression and other mental illnesses rank as the third
highest economic burden resulting from healthcare needs, after hypertension and heart disease
(Goetzel et al., 2004). Estimates suggest that the total economic burden of depression is
approximately $83.1 billion, 62 percent of which are related to workplace costs (Greenberg et al.,
2003). Thus, IPC can aid in facilitating overall reduction in healthcare costs and loss of
workplace productivity by addressing mental health needs. Onsite behavioral health specialists
can serve to increase medical clinic revenues by billing for patient care as well as alleviating
medical providers from spending time on mental health issues, allowing them to see more
patients (Miller et al., 2009). Mental health treatment offered through primary care tends to be
less expensive for patients compared to specialty mental health services, which are often not
covered under insurance (A. Blount, 2003).
6

Neuropsychology in Integrated Primary Care
Although IPC is a relatively new field of practice, it is continually evolving to adapt to
the patient-centered medical home. Given its infancy, research in IPC remains limited; however,
more recent research has explored the role of neuropsychology in primary care (Kubu et al.,
2016; Michels et al., 2010). Neurocognitive impairment is a correlate of medical disorders,
including liver disease, kidney disease, cardiac disease, and even more common diagnoses such
as diabetes. Additionally, cognitive impairment has been identified as a barrier to successful
treatment, because it adversely impacts a patient’s capacity to execute complex medical orders,
maintain medication compliance, and provide appropriate information to medical staff. Given
this growing awareness about cognitive health and disability has spurred a greater recognition of
the value and import of neuropsychological assessment as a standard component of integrated
medical care (Block, Johnson-Greene, Pliskin, & Boake, 2017).
While the goals of neuropsychological assessment typically relate to the referral question,
generally, neuropsychology can promote functional independence of patients, facilitate
diagnosis, and help with patient care and treatment planning (Lezak, 2004). With regard to
cognitive screening in primary care, practicing physicians have acknowledged the importance of
recognizing and identifying cognitive impairment among their patient population, however,
important barriers, such as added visit time, as well as uncertainty in administering diagnostic
measures, still exist (Borson et al., 2007; Harvan & Cotter, 2006). Although there is not a
singular instrument that has been denoted as the gold standard for cognitive screening, clinician
surveys indicate that the Mini-Mental State Examination (MMSE) is the most widely used and
recognized instrument in practice. Despite its extensive use, the MMSE has notable limitations
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regarding its sensitivity and vulnerability related to education, culture, and language of
administration (Cullen, O’Neill, Evans, Coen, & Lawlor, 2007; Shulman et al., 2006). An
additional issue related to the MMSE is its ceiling effect, which equates to a limited dynamic
performance range for normal individuals. This increases the probability that individuals in predementia stages score within the normal range. The MMSE has been cited for having poor
sensitivity for distinguishing mild cognitive impairment (MCI), likely attributed to a lack of
complexity as well as the absence of executive function items (Trzepacz, Hochstetler, Wang,
Walker, & Saykin, 2015).
The Montreal Cognitive Assessment (MoCA) is another commonly used clinical
instrument utilized in the screening of cognitive functioning. Past literature has found the MoCA
to have superior sensitivity over the MMSE in detecting MCI. Reasons for this likely include
more stringent cognitive assessment criteria such as more words in the memory testing, fewer
learning trials, and a longer delay before recall than the MMSE. Additionally, the MoCA utilizes
higher-level language abilities and complex visuospatial processing. Overall, the literature
indicates that the MoCA’s increased sensitivity can be attributed to more numerous and
demanding tasks than the MMSE. Nevertheless, it has been noted that the MoCA should only be
utilized as a screening tool. The information gained from administering the MoCA should be
used to provide quick guidance for referral and further, more comprehensive, investigation of
potential cognitive impairment (Larner, 2012; Nasreddine et al., 2005).
While the use of validated cognitive screening tools certainly informs and improves
clinical practice for healthcare providers, screening measures were never intended to be used in
lieu of neuropsychological evaluation (Kubu et al., 2016; Larner, 2012; Nasreddine et al., 2005;
8

Temple, Carvalho, & Tremont, 2006). Noted elsewhere, there exist tangible barriers to
neuropsychological evaluation, not the least of which is the lengthy waitlist time that is common
in urban healthcare centers nationwide and reliance on the process of patient referral and postevaluation record transmission, particularly with patients who may have cognitive impairment
(Borson, Scanlan, Watanabe, Tu, & Lessig, 2006; Kubu et al., 2016; Temple et al., 2006).
Ultimately, having access to onsite neuropsychological services may aid in alleviating some of
these barriers.

Subjective Cognitive Decline
Identification of candidates for neuropsychological evaluation can result from numerous
events – reported concern of a patient’s family member, clinical decision making by medical
staff, and subjective report of cognitive change, among others. Subjective cognitive decline
(SCD) in older adults is increasingly recognized as a possible sign of non-normative cognitive
aging, which could eventually progress to a diagnosis of dementia (Rabin et al., 2015; Snitz,
Morrow, Rodriguez, Huber, & Saxton, 2008). Recent research has shown an association between
SCD and biomarkers as well as neuroimaging markers of Alzheimer’s disease (AD), in the
absence of objective cognitive dysfunction or depression. Given research supporting SCD as a
risk factor for AD in some individuals, the National Institute on Aging–Alzheimer’s Association
preclinical AD working group has included SCD as a facet, emphasizing its importance in
disease detection and prevention (Rabin et al., 2015). Further, the presence of subjective
cognitive concerns has been considered to be one of the first symptoms of cognitive impairment,
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and as one of the general core and cognitive criteria for the early diagnosis of mild cognitive
impairment (Juncos‐Rabadán et al., 2014).
Subjective cognitive complaints are common in older adult patients, who typically
present to their primary care providers. Thus, providers located in a primary care setting could
play a critical role in the early detection of cognitive impairment. Further, the Alzheimer’s
Association has recommended cognitive assessment in primary care settings, as a way to aid in
reducing the prevalence of missed or delayed dementia diagnoses (Rabin et al., 2015). In a
sample of older adult primary care patients (mean age 73.2) Snitz and colleagues (2008) found
that self-reports of current memory ability were associated with objective memory performance.
Further, in a study of older adult, community-dwelling volunteers, results indicated that 80% of
individuals with MCI endorsed subjective memory complaints (De Jager & Budge, 2005).
Subjective cognitive decline is assessed by self-report of cognition. This assessment
approach is associated with advantages such as brevity, ease of administration, and low cost.
However, past research has documented the disadvantage that, currently, the field lacks a single
accepted approach in assessing SCD. These studies have cited the need for additional research to
clarify the nature of the questions assessing functioning (present status versus decline), as well as
cognitive domains of greatest interest, and optimal items for each domain (Rabin et al., 2015;
Snitz et al., 2008).
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Proposed Research
The overall purpose of this study was to examine the effectiveness and feasibility of a
brief neuropsychological battery, for memory concerns, in a community primary care setting.
Specifically, we hypothesized that:
Hypothesis 1: The number of neuropsychological referrals for the onsite clinic would be
greater than those made previously for outside referrals (compared on a consistent ninemonth timeframe), on account of access to readily available onsite services.
Hypothesis 2: Accessibility of results of neuropsychological evaluations would increase
as a result of onsite services. Accessibility was assessed by comparing presence of
neuropsychology reports in the UCF Health EMR for those patients who received outside
referrals, to the number of such reports for patients referred for integrated neurocognitive
assessment.
Hypothesis 3: Scores on the measure of subjective cognitive decline would be
significantly correlated with performance on measures of neurocognitive functioning.
Specifically, it was hypothesized that SCD scores would correlate with an individual’s
(Hypothesis 3A) RBANS Total Scale Score, (Hypothesis 3B) RBANS Delayed Memory
subscale score, and (Hypothesis 3C) Trails B performance score.
Hypothesis 4: Provider satisfaction with available neuropsychological services would
increase as a result of having access to onsite neuropsychological services as measured
by scores on the provider survey. Baseline satisfaction levels were measured prior to
beginning onsite neuropsychological services and then compared to respondent scores
following the completion of the trial period for this onsite clinic.
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CHAPTER 2: METHODS
Study Participants
The present study utilized data from both patient participants and medical providers from
an outpatient academic medical center.

i. Patient Participants
Participants were recruited from the patient population of an outpatient academic medical
center providing both primary and specialty healthcare. Medical providers practicing at this
medical center during the course of the study helped to identify patients who may have been
experiencing cognitive difficulties (e.g., memory problems). Providers verbally informed
patients of the research study and if the patient was interested, entered a referral into the EMR
system, which was routed to the study coordinators. Patients could also refer themselves to the
study. Once the study coordinator received the patient’s information, the patient was then
contacted to assess for appropriateness of study inclusion. Inclusion criteria included being 18years of age or older and demonstrated fluency in English. Prospective participants who had an
existing diagnosis of dementia and/or Major Neurocognitive Disorder, Moderate or Severe, were
excluded, unless accompanied by their healthcare proxy, who legally held medical power of
attorney for the diagnosed individual and agreed to provide consent, while assent was attained
from the patient. Additional exclusion criteria included individuals who were actively pursuing
litigation related to their neurocognitive functioning and/or previously referred-for
neuropsychological services. Patients who consented to participate in the study were then
enrolled as participants. Individual assessment services and/or community referrals were
12

available to patients who did not meet study criteria or who elected not to participate in the
study.
Patients that met study criteria were then scheduled for an individual interview and
neurocognitive evaluation. During this appointment, they were also given study information,
provided informed consent, were interviewed about their cognitive functioning, and completed
study questionnaires. After completing the testing session, participants were scheduled for a
follow-up session, during which results and recommendations from their evaluation were
reviewed. A total of 23 patients were referred for the study. Of those, 4 were unable to be
reached and 3 declined services after further information was provided. A total of 16 participants
enrolled in and completed the study. All study-related activity took place in the outpatient
healthcare clinic and was approved by the University Institutional Review Board and clinic
administration.

ii. Medical Providers
Medical providers who were practicing at UCF Health during the study were asked to
participate in a provider survey assessing facets of satisfaction related to the availability of
neuropsychological services. Both primary care and specialty care providers were invited to
participate, including those who practice in cardiology, endocrinology, family medicine,
gastroenterology, geriatric medicine, nephrology, neurology, pulmonology, and rheumatology,
among others.
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iii. Previously referred patients
Participants from UCF Health, who were previously referred for outside
neuropsychological services from UCF Health, were also included in the study in order to
ascertain the number of referrals made as well as to evaluate the absence or presence of a
neuropsychological report contained within their medical record. No other information from their
electronic medical record was accessed. Included participants in this subsample consisted of
those who received a referral for neuropsychological assessment in the community between
February 1, 2017 and October 31, 2017.

iv. Proposed sample size – enrolled participants
A thorough review of the literature suggests that, the practice of clinical neuropsychology
is expanding in that there is no longer only limited interaction with other healthcare providers.
Previous research has found that the role and value of clinical neuropsychology on integrated
care teams is not confined to clinical assessments and has evolved to include a wide range of
services provided to a diverse spectrum of healthcare teams (Kubu et al., 2016; Michels et al.,
2010). Studies have shown that primary care physicians found neuropsychological services to be
useful; integrating information from the neuropsychological evaluation into their patient
recommendations as well as physician discharge summaries (Temple et al., 2006). However,
despite the well-documented utility of neuropsychological services within an integrated
healthcare team, research on the feasibility of these services is lacking. Further, of the available
research in this area, most studies do not separate the neuropsychological components (i.e.,
assessment and treatment) from the complete integrated, multidisciplinary intervention. A study
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by Heinemann and colleagues (1995) found that, compared with physical, occupational, and
speech therapy, neuropsychological services focused on remediating cognitive deficits resulted
in significantly better functional outcomes for patients who had suffered either a traumatic brain
injury or spin cord injury. Other studies have supported the fiscal-effectiveness of integrated
neuropsychological services on healthcare teams (Aronow, 1987; Wolfs, Dirksen, Kessels,
Severens, & Verhey, 2009). Thus, while there are some promising studies examining aspects of
integrated neuropsychological services, additional studies are needed to elucidate the feasibility
and efficacy of these services within an integrated healthcare team in a community primary care
setting.
The number of participants in the sample of clinical service providers was inherently
limited by the number of respondents among the UCF medical staff. Other studies that have
investigated aspects involving integrated neuropsychological services have had sample sizes
ranging from 18 to 55 participants, in populations of individuals with traumatic brain injury
(Conneeley, 2012) and HIV-associated neurocognitive disorder (Kamminga et al., 2017),
respectively.

Method
v. Feasibility, efficacy, and accessibility
Data investigating the feasibility, efficacy, and accessibility related to the onsite clinic
was assessed with various approaches. More specifically, this included an analysis of the number
of referrals made for outside neuropsychological services over a nine month period as well as the
absence or presence of a neuropsychological report contained within the medical record (no
15

other information from the medical record was accessed, outside of if a referral was made and
investigating whether or not a neuropsychological report had been scanned in and/or attached to
their EMR). This data was provided via an honest broker (an individual from the UCF Health IT
Team), to maximize the protection of patient PHI.

vi.Patient Participants
Participants who consented to enroll in the study were scheduled for an evaluation and
brief interview. The evaluation included testing measures that examined the participant’s
neurocognitive functioning across domains of attention, language, visuospatial/constructional
abilities, immediate and delayed memory, premorbid reading level, confrontation naming, and
executive function. Components of current emotional status and perception of cognition were
also examined via self-report measures completed by the participant. Once testing was
completed, all materials were scored, and a brief report, describing their results and how these
results compare to others of similar age, gender, and education level was composed. The primary
goal of the report was to allow the participant and/or provider to gain a better understanding of
the relationship of the participant’s scores to normal and abnormal cognitive performance. All
reports were reviewed and signed by a licensed psychologist, prior to being placed in the
participant’s medical record. Following this, a feedback session with the participant was
scheduled, during which results and subsequent recommendations were reviewed, and the
participant was given ample time to ask questions for clarification.
Patient satisfaction with onsite clinic services was also measured, This was done with an
anonymous survey, to ensure patient confidentiality. The survey assessed components related to
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ease of access regarding the onsite clinic, utility of services, adequate acknowledgement of
presenting concerns, and helpfulness of feedback and subsequent recommendations. The survey
was administered following the feedback session.

vii.Medical Providers
Data assessing provider satisfaction with available neuropsychological services was
collected via an electronically distributed anonymous Qualtrics survey. They survey assessed
facets of satisfaction related to the availability, utility, and usefulness of services. The survey
was administered prior to the beginning of the proposed onsite clinic and again at the end of the
trial period for this clinic, in order to better understand satisfaction related to neuropsychological
services both before and after onsite services were implemented.

Measures
Demographic Variables. Participants provided information on the following demographic
information.
Age. Participants provided their date of birth.
Sex. Participants identified their sex by indicating either male, female, or other.
Ethnicity. Participants identified their ethnicity by indicating one of the following
choices: African-American/Black; American Indian/Native Alaskan; Asian/Southeast
Asian/Asian-American; Caucasian/European/White; Native Hawaiian/Other Pacific Islander; or
Latino(a)/Hispanic.
Level of Education. Participants identified their highest level of education completed.
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Existing diagnoses. Participants verified the accuracy of existing diagnoses within their
medical records.
Medications List. Participants verified the accuracy of current medications listed within
their medical records via verbal confirmation of the listed information.
Assessment Measures.
Repeatable Battery for Neuropsychological Status (RBANS). The RBANS is a brief,
individually administered test, which measures attention, language, visuospatial/constructional
abilities, and immediate and delayed memory. The RBANS is comprised of 12 subtests, which
generate five Index scores as well as a Total Scale score (Duff, Hobson, Beglinger, & O'Bryant,
2010). Research has found the RBANS to be valid and reliable across age ranges and various
populations, including neurological populations such as those who have suffered traumatic brain
injury (TBI), stroke, and concussion, among others. The RBANS has demonstrated high internal
consistency (0.88) and test-retest reliability (Randolph, 1998).
National Adult Reading Test (NART). The NART is a measure of premorbid
functioning. It is a reading test comprised of 50 single word items of graded difficulty. The
words are irregular, as they contradict typical grapheme-phoneme correspondence rules. The
NART has demonstrated high internal consistency, test-retest reliability, and inter-rater
reliability (0.90, 0.98, and 0.88, respectively) (Uttl, 2002).
Boston Naming Test-II (BNT-II). The BNT-II is a confrontation naming task, which
assesses an individual’s ability to retrieve different types of words. Confrontation naming can
include pictures of objects, which tests noun retrieval or pictures of actions, which tests verb
retrieval. Confrontation naming tasks often are included in clinical testing to detect impairments
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in word-finding abilities in individuals with various types of neurologic impairments (Spreen &
Risser, 2003). The BNT-II is the most common test of confrontation naming (Kaplan,
Goodglass, & Weintraub, 2001). This test requires an individual to identify line drawings of
common man-made, as well as naturally occurring, objects. The BNT-II has demonstrated a high
test-retest reliability (r = 0.91; (Morris et al., 1989; Welsh-Bohmer & Mohs, 1997).
Reitan Trail Making Test, A and B. The trail making test is administered in two parts;
A and B. For Part A, the subject is asked to draw lines connecting consecutively numbered
circles on a worksheet. Part B asks that the subject connect consecutively numbered and lettered
circles by alternating between the numbers and letters. The test-retest reliability is moderate to
high for Part A (r=.36 to .79) and Part B (r=.44 to .89). In addition, inter-rater reliability has been
found to be high for both Part A r=(.94) and Part B (r=.90) and content validity has been shown
to correlate moderately between Part A and B (Reitan, 1958).
Generalized Anxiety Disorder-7 (GAD-7): The GAD-7 is a self-report measure that
assesses severity of symptoms associated with anxiety. The GAD-7 has been found to be a
reliable and valid measure across several populations. It produces an overall score with cutoffs to
identify points for mild, moderate, and severe symptoms associated with anxiety. The GAD-7
has demonstrated good internal consistency (0.92), test-retest reliability (0.83), procedural
validity, and construct validity (Mills et al., 2014).
The Geriatric Depression Scale (GDS). The GDS is a self-report measure of depression
in older adults, in which individuals respond in a “Yes/No” format. The GDS was originally
developed as a 30-item instrument, however, since its initial version, a 15-item version was
developed. The shortened form is comprised of 15 items chosen from the Geriatric Depression
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Scale-Long Form (GDS-L). The GDS-15 has been found to have good sensitivity and specificity
for detecting depression (88% and 64% respectively), as well as high internal consistency (0.94;
(Agrell & Dehlin, 1989; Sheikh & Yesavage, 1986)). Additionally, the GDS has been found to
be a useful tool in medical settings, with medically complex patients given that there may be a
high level of decreased activity, as well as those with comorbid cognitive impairment (Kieffer &
Reese, 2002; Weintraub, Saboe, & Stern, 2007).
Everyday Cognition, Self-Report Form (ECog). The ECog is a multidimensional,
psychometrically sound measure of everyday function in older adults. The ECog measures
everyday function in multiple domains (memory, language, visual-spatial and perceptual
abilities, executive functioning (planning, organization, and divided attention)). The ECog has
been found to be a reliable and valid measure across groups of normal aging, those with mild
cognitive impairment, and those with a diagnosis of dementia (α = .96, test-retest reliability, r =
.82, p < .0001; (Farias et al., 2008)).
Provider Satisfaction Survey. Providers were asked to complete a provider experience
survey to evaluate components of satisfaction related to having access to onsite integrated
neuropsychological services at UCF Health. The survey was created for purposes of the current
study, however, existing surveys were referenced when creating the current provider satisfaction
survey (Hine et al., 2017). The survey consists of 9 statements assessing varying domains of
satisfaction related to neuropsychological services (e.g., “Neuropsychological services that are
available to my patients have been very useful in determining diagnoses”; “When referred, my
patients have been able to schedule neuropsychological evaluations in a timely manner”; “The
available neuropsychological services provide timely reports after my patients have been seen”;
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and “Results of neuropsychological evaluations have helped to inform my practice and patient
care.”). Providers rate their agreement with these 9 statements on a 5-point Likert scale from 1
(Strongly Disagree) to 5 (Strongly Agree). The survey also includes one question, asking
providers to rate their overall satisfaction with neuropsychological services (0 = Not at all
satisfied, 10 = Completely satisfied). Lastly, the survey asks two open-ended questions allowing
providers to identify the most and least helpful aspects related to neuropsychological services.
Patient Satisfaction Survey. Participants were asked to complete a patient experience
survey to evaluate components of satisfaction related to receiving integrated neuropsychological
services at UCF Health. The survey was created for the current study purposes, however, survey
items were adapted from existing patient satisfaction measures (Ede et al., 2015). The survey
consists of 11 statements assessing varying domains of the onsite clinic (e.g., “Any concerns I
may have had regarding my cognitive status were addressed quickly”; “Testing and results were
provided to me in a language or way I could easily understand”; “I feel I was provided with
helpful recommendations to address my cognitive concerns”; and “I feel that feedback supplied
by my cognitive health specialist, to my medical provider, was helpful in coordinating my
care.”). Participants rate their agreement with these 11 statements on a 5-point Likert scale from
1 (Strongly Disagree) to 5 (Strongly Agree). The survey also includes one question, asking
participants to rate their overall satisfaction with the onsite clinic (0 = Not at all satisfied, 10 =
Completely satisfied). Lastly, the survey asks two open-ended questions allowing participants to
identify the most and least helpful aspects of the onsite service.
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Statistical Methods
Descriptive statistics were employed to characterize sub-samples of participants as well
as medical providers. Comparisons examining the number of neuropsychological referrals were
done using Chi-square statistics for categorical variables (hypothesis 1). Comparisons examining
the accessibility of neuropsychological reports were made using Chi-square statistics for
categorical variables (hypothesis 2). Associations between measures of objective cognitive
performance and subjective cognitive decline scores were tested using bivariate Pearson
correlations (hypothesis 3). Analyses examining the relationship between subjective and
objective cognitive performance were performed both with and without inclusion of the GDS-15
depression score and years of education as control variables. An additional analysis examining
participants’ satisfaction with the onsite clinic was addressed using descriptive statistics.
Comparisons between pre- and post- levels of provider satisfaction were made using an
independent samples t-test (hypothesis 4). All data were analyzed using IBM SPSS Statistics 23.
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CHAPTER 3: RESULTS
Feasibility, efficacy, and accessibility
The number of neuropsychological referrals made during the time of the onsite clinic was
compared to that of the same length, prior to the start of the onsite clinic. To ascertain whether a
difference was present in the number of referrals made during the time of the onsite
neurocognitive clinic (September 2018 – May 2019) and those made in a nine-month period
prior to the start of onsite services (February 2017 and October 2017), a Pearson chi-square was
conducted. More specifically, in total, 23 referrals were made to the onsite clinic, with 16
patients enrolling as study participants. The number of enrolled study participants (16) was
significantly more than the 10 referrals that had been made in the nine-month period for outside
neuropsychological services, prior to the start of this study (χ2(1) = 26.00, p < .001, V = 1.00).
Regarding accessibility of neuropsychological reports, an additional chi-square was conducted to
compare the accessibility of reports during the onsite clinic as compared to those that had been
referred for outside neuropsychological services, prior to the commencement of the onsite clinic.
For those who had received services at the onsite neurocognitive clinic, the number of reports
located within the patient’s EMR was significantly greater than those who had received outside
services (χ2(1) = 22.02, p < .001, V = .92).

Patient Participants
A total of 16 participants enrolled in and completed the study. As displayed in Table 1,
participants were on average 67.75-years-old, predominantly female (56.3%), Caucasian
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(93.8%), partnered (75.0%), and cohabitated with another individual (75.0%). Participants had
an average of 17.25 years of education and 2.38 medical diagnoses.
A reliability analysis was conducted for each domain of the subjective cognitive decline
measure. These analyses revealed high internal consistency across all domains, including
memory, which consisted of 8 items (α = .94); language, which was comprised of 9 items (α =
.96); visuospatial, which included 7 items (α = .97); and executive function, which contained 15
items (α = .98). Following this, associations between subjective cognitive decline and scores on
measures of neurocognitive function were tested using bivariate Pearson correlations (see Table
2). Assumptions of bivariate normality were assessed visually utilizing a scatterplot of the data
points. Results revealed that subjective cognitive decline scores as well as scores on objective
measures of cognitive performance, including the RBANS Total Scale Score, RBANS Delayed
Memory Index Score, and Trails B violated the assumptions of bivariate normality. Thus, square
root transformations were performed on the data, in an effort to normalize the data (Tabachnick
& Fidell, 2013). This transformation eliminated the violation of bivariate normality for
subjective cognitive decline and objective cognitive performance scores. Results did not indicate
a significant correlation between subjective cognitive decline scores and RBANS Total Scale
Scores (r(14) = .20, p = .46); subjective cognitive decline and RBANS Delayed Memory Index
Score (r(14) = .06, p = .84); or subjective cognitive decline and Trails B performance (r(14) = .02, p = .94). Additional analysis with the inclusion of GDS-15 depression scores and years of
education as control variables were also performed (see Table 3). Results from these analyses did
not indicate a significant correlation between subjective cognitive decline scores and RBANS
Total Scale Scores (r(12) = .04, p = .89); subjective cognitive decline and RBANS Delayed
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Memory Index Score (r(12) = .01, p = .99); or subjective cognitive decline and Trails B
performance (r(12) = -.32, p = .27). A post-hoc analysis was conducted with the inclusion of
GAD-7 scores and years of education as control variables. Results from these analyses also did
not indicate a significant correlation between subjective cognitive decline scores and RBANS
Total Scale Scores (r(12) = .06, p = .83); subjective cognitive decline and RBANS Delayed
Memory Index Score (r(12) = -.03, p = .93); or subjective cognitive decline and Trails B
performance (r(12) = -.42, p = .14).
In order to better understand the relationship between subjective cognitive decline and
neurocognitive function among participants, auxiliary analyses, examining the relationship
between specific domains of subjective cognitive decline (e.g., executive function), as measured
by the Ecog, and corresponding measures of neurocognitive functioning (i.e., Trails B) were also
performed. Results did not indicate a significant correlation between subjective cognitive decline
of language and BNT Scores (r(14) = .09, p = .75); COWAT scores (r(14) = -.15, p = .58); or
RBANS Semantic Fluency (r(14) = .28, p = .30); nor between subjective cognitive decline of
visuospatial skills and RBANS Figure Copy (r(14) = .06, p = .82), or RBANS Visuospatial Index
Score (r(14) = .04, p = .88). Results also did not indicate a significant correlation between
subjective cognitive decline of memory and RBANS Delayed Memory Index Score (r(14) = .15,
p = .59) nor between subjective cognitive decline of executive function and RBANS Coding
(r(14) = .29, p = .26) or Trails B (r(14) = -.01, p = .96; see Table 4).
Participant satisfaction was measured from 15 participants (the final participant has not
yet returned for their feedback session). Survey results revealed that, overall, participants were in
agreement with the following statements about the onsite neurocognitive clinic: (1) I am satisfied
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with the amount of time the cognitive health specialist spent with me during my visit (M = 4.87,
SD = 0.35); (2) My beliefs about my health and well-being were considered as part of the
services that I received (M = 4.73, SD = 0.59); (3) I would follow through if I were referred
outside this clinic for neuropsychological testing services (M = 4.67, SD = 0.62); (4) Any
concerns I may have had regarding my cognitive status were addressed quickly (M = 4.60, SD =
0.63); (5) Testing and results were provided to me in a language or way I could easily understand
(M = 4.93, SD = 0.26); (6) I am comfortable receiving cognitive health services here at this clinic
(M = 4.60, SD = 1.06); (7) I am treated the same as other people who get care at the clinic (M =
4.73, SD = 0.70); (8) I prefer to receive my cognitive health services at the location where I
receive my medical care (M = 4.80, SD = 0.56); (9) I feel I was provided with helpful
recommendations to address my cognitive concerns (M = 4.93, SD = 0.26); (10) I feel that
consultation between my medical provider and cognitive health specialist was helpful to me (M =
4.80, SD = 0.56); and (11) I feel that feedback supplied by my cognitive health specialist, to my
medical provider, was helpful in coordinating my care (M = 4.53, SD = 0.83). Participants
reported overall satisfaction with the services of the onsite clinic (M = 9.80, SD = 0.56). Please
refer to Figure 2 for depiction of results.

Medical Providers
In total, nine satisfaction surveys were returned; with six having been completed at the
pre-survey and three at the post-survey. It should be noted that, as the survey was submitted
anonymously, it is not possible to confirm that the same providers submitted responses for the
pre- and post-surveys. Therefore, an independent samples t-test was run to determine if there
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was a statistically significant difference in the mean of the pre-survey overall satisfaction level
and post-survey overall satisfaction level among medical providers. Homogeneity of variance
was assessed using Levene’s test for equality of variances and this assumption was met for the
analysis (p > .05). Results revealed a significantly higher level of overall satisfaction with
neuropsychological services following the onsite clinic (post-survey; M = 8.67, SD = 1.16) than
indicated prior to the start of onsite services (pre-survey; M = 5.83, SD = 1.84; t(7) = -2.40, p =
.04). Despite this, an aspect that must be acknowledged is the marginal statistical power
associated with these analyses, due to the limited sample size, and results should not be
overinterpreted. Nevertheless, medical providers endorsed significantly higher levels of
satisfaction at post-survey related to the following components: (1) timely scheduling of referred
patients for neuropsychological services (t(7) = -12.98, p < .001); (2) timely completion of
reports following patient appointment (t(7) = -2.59, p = .04); (3) ease of accessibility of
neuropsychological reports (t(7) = -2.59, p = .04); (4) interaction with neuropsychological
providers (t(7) = -3.36, p = .01); and (5) availability of neuropsychological services (t(7) = -3.46,
p = .01). Please refer to Figure 3 for depiction of results.
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CHAPTER 4: DISCUSSION
The primary purpose of this study was to evaluate efficacy and feasibility related to the
implementation of an onsite neurocognitive clinic within an outpatient academic healthcare
setting. Overall, results supported hypothesis 1, with an increased number of neuropsychological
referrals for the onsite clinic in comparison to those made for outside neuropsychological
services during a nine-month period. Hypothesis 2 was also supported, as accessibility of
neuropsychological evaluations located in the EMR increased for those who received onsite
services, when compared to those who had received outside referrals. No significant correlations
were found between subjective cognitive decline scores and measures of neurocognitive
functioning, including RBANS Total Scale Score, RBANS Delayed Memory Index score, and
Trails B performance. Results were also insignificant when controlling for years of education
and GDS-15 scores as well as for a post-hoc analysis which included GAD-7 scores and years of
education as control variables. Satisfaction survey results revealed that, overall, participants were
satisfied with and found onsite services to helpful. Medical provider satisfaction was
significantly higher following implementation of the onsite clinic than indicated at baseline
levels, which were measured prior to the start of onsite services. Medical providers identified
increased overall satisfaction, as well as satisfaction related to timely scheduling of referred
patients, timely completion of and access to neurocognitive reports, as well as interaction with
neuropsychological providers. However, the limited sample size and marginal statistical power
associated with analyses surrounding provider satisfaction are important caveats to interpretation
of these results.
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Analyses did not find a significant correlation between measures of subjective cognitive
decline and performance on objective measures of neurocognitive performance. Additional
auxiliary analyses of SCD and objective test performance via specific domains (e.g., executive
function and Trails B), were also non-significant. One possible reason for non-significant results
may be due to the small sample size of the current study. Overall, the literature on the
relationship between subjective cognitive decline and objective test performance presents highly
varied findings, characterizing a complex relationship between SCD and objective cognitive
performance. Snitz and colleagues (2008) found that self-reports of current memory ability were
associated with objective memory performance in a sample of older adult patients in a primary
care setting. Similarly, Rattanabannakit et al. (2016) found that participant and informant ratings
of cognitive impairment were associated with objective scores on cognitive measures, even after
adjusting for demographic variables and depressive symptoms. Conversely, Zlatar and
colleagues (2017) did not find a significant association between SCD and objective cognition,
after adjusting for both demographics and depression, in a sample of older adults referred for
memory concerns. Additional studies have revealed similar findings to that of Zlatar et al.
(2017), in that SCD was not significantly associated with objective cognitive measures,
particularly after controlling for mood and demographic variables , and suggest that subjective
cognitive complaints are less likely to be related to co-occurring cognitive impairment, and more
likely related to depressive symptoms (Alegret et al., 2015; Balash et al., 2013; Zlatar, Moore,
Palmer, Thompson, & Jeste, 2014). Further, Burmester, Leathem, and Merrick (2016) conducted
a meta-analysis investigating how subjective cognitive complaints might reliably indicate
impairments in objective cognitive function. Their results indicated a small but significant
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association between subjective cognitive complaints and objective cognitive function, with
stronger links between subjective complaints and depressive symptoms. It is possible that the
results of the current study may serve as additional evidence in this complex relationship, though
limitations related to samples size and subsequent statistical power should be acknowledged.
An additional possibility for the non-significant findings between SCD and objective
neurocognitive data may also be related to the particular group of patient participants. More
specifically, it is possible that our patient participants represent a group more consistent with
those who have been previously referred to as the “worried well,” which describes patients who
are hypersensitive to and anxious about memory changes, but do not show objective findings on
neuropsychological testing (Kinzer & Suhr, 2016; Thompson, Henry, Rendell, Withall, &
Brodaty, 2015). These “worried well” patients are likely to interpret everyday cognitive lapses as
an indication of decline or impairment in memory (Kinzer & Suhr, 2016). It is also possible that
individuals presenting with the primary concern of memory impairment or potential dementia,
may not provide an altogether accurate report of their current neurocognitive functioning (Kinzer
& Suhr, 2016). These positions highlight the findings of previous studies that have indicated the
likelihood of individuals presenting with SCD representing the “worried well,” rather than those
with true impairment (Amariglio et al., 2012).Although results of a post-hoc analysis did not find
a significant correlation between SCD and objective test scores when controlling for GAD-7
scores and years of education, considerations surrounding limited sample size should be taken
into consideration. In addition, the GAD-7 was designed as a screening tool to assess symptom
severity. While the brevity of the GAD-7 facilitates an efficient approach to tracking symptoms
and response to treatment, it is possible that it was not specific enough to detect worry related to
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cognitive symptoms or difficulty with cognitive functioning. Future research may aim to further
assess anxiety related to perception of current cognitive difficulties during the interview with the
patient to gain a better understanding of the impact this may have on subsequent results. Further,
as past studies have also shown an association between negative stereotypes about age-related
cognitive decline and subsequent decreased performance on neurocognitive measures (Arnett,
2013; Barber & Mather, 2014; Suhr & Kinkela, 2007), future research may also aim to account
for the possibility of this stereotype threat, which may influence the relationship between SCD
and objective test performance.
A strength of the current study includes the increased satisfaction levels among medical
providers related to onsite neurocognitive clinic services. Moreover, satisfaction levels for the
clinic were high among both medical providers and patient participants. Despite this, the referral
rate for clinic services was generally slow throughout the study. While the clinic was rated as
providing useful, beneficial services, and was largely well-liked by both patients and providers,
the overall low referral rate reflects an underutilization of clinic services in this particular
application. Extant literature suggests that, as a whole, neuropsychology’s integration into
primary care settings, and onto integrated care teams, has not happened quickly (Festa, 2018;
Ruchinskas & Cullum, 2018). In a community based academic hospital system, the integration of
neuropsychology into primary care clinics required a six-month timespan to resolve logistic
hurdles alone (e.g., available space, referral flow); as well as an additional six-month time period
following implementation, during which guidelines were established to inform appropriateness
of referrals and the subsequent referral stream was better developed and refined (Lanca, 2018).
Although this can be a prolonged process, the integration of neuropsychology into primary care
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is generally quite well received, with high levels of satisfaction with neuropsychology indicated
by other team members (Kubu et al., 2016; Lanca, 2018; Ruchinskas & Cullum, 2018). With
ample time, it appears that similar clinics offering neuropsychological services, and operating
within primary care settings, have overcome difficulties with low referral rates and are largely
well utilized, employing waitlists that span several weeks to several months out (Lanca, 2018;
Lanca & Meisinger, 2019; Ruchinskas & Cullum, 2018).
The results of the current study suggest multiple ways in which integrated
neuropsychological assessment improves access to and quality of delivered health care. The
Alzheimer’s Association has recommended cognitive assessment in primary care settings, as a
way to aid in reducing the prevalence of missed or delayed dementia diagnoses. Research
indicates that providers located in a primary care setting play a critical role in the early detection
of cognitive impairment, as older adults with subjective cognitive complaints typically present
first to their primary care providers (Rabin et al., 2015). Additionally, early cognitive decline is
associated with greater use of primary care services (Fowler et al., 2012; Ganguli et al., 2004).
Thus, there is a clear need for cognitive assessments that are both accessible and efficient within
a primary care setting to meet the needs of this growing patient population. Integrating
neuropsychological testing into primary care improves access for patients and allows primary
care teams to incorporate neuropsychological results into subsequent case conceptualization,
diagnosis, and patient care (Lanca, 2018; Lanca & Meisinger, 2019; Ruchinskas & Cullum,
2018). As the current study documented directly in the EMR, neurocognitive reports were easily
accessible to the referring provider, which facilitated cohesive coordination of care for the

32

patient. Onsite clinic services allowed for greater access to cognitive assessments, as well as
improved awareness and management of cognitive symptoms for both patients and providers.
Despite the general findings related to increased referrals, accessibility of neurocognitive
reports, and satisfaction with services, several barriers to the feasibility of a clinic of this nature
were present. Although onsite clinic services were co-located in the primary care setting, it is
possible these services were not viewed as being fully part of the integrated services available to
patients and providers, This may have been due to the lack of availability of daily services (e.g.,
neurocognitive evaluations only scheduled two days per week) as well as services being
delivered by a Master’s level trainee. While these components are consistent with the nature of a
research study, it is possible that these factors limited the extent to which clinic services and
providers were viewed as a part of the integrated care team. In addition, numerous structural
changes occurred throughout the course of this study, including migration to a new EMR system.
During the transition to the new EMR system, several internal processes were disrupted
including the process by which referrals are initiated and processed in the EMR system. Due to
the period of time this functionality was inaccessible, it likely affected referral rate during that
timeframe. Future studies may aim to incorporate supplemental methods for referrals during an
EMR transition when the referral system is compromised. This could include frequent check-in
with providers or in-session consultation with patients during their medical appointment. It is
possible that this approach, akin to a “warm handoff,” would moderate the decrease in referrals
and subsequent productivity of such a clinic. Additionally, several personnel changes transpired
while the study was ongoing, including the loss of medical providers along with the addition of
new providers. It is likely that these changes influenced referral rate, as it is possible that new
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providers were unaware of onsite services, despite study coordinator’s best efforts to consistently
remind providers of the onsite clinic. Research has indicated the importance of continually
providing education to medical providers about the benefits and usefulness of neuropsychology
as well as the ways that neuropsychologists can participate in patient care. Efficient assessments
and feasible recommendations for patients can provide helpful information for medical providers
and improve overall patient care (Festa, 2018; Lanca, 2018; Mercury, Kehoe, & Tschan, 2007).
As staffing changes in health centers are common, future research should consider utilizing
regular education sessions for medical providers, perhaps during monthly provider meetings or
grand rounds. This could serve to not only remind current providers about the presence and
utility of onsite services, but would also ensure that new providers were aware of such services,
while also mitigating the potential loss of referrals. Perhaps the most significant change that
occurred during the study timeframe included the dissolution of the behavioral health team. The
Director of the behavioral health team made repeated efforts to increase awareness of clinic
services, as well as the benefit to both patients and providers. It is expected that the conclusion of
behavioral health services greatly impacted potential referrals. Overall, the multitude of
structural changes that took place during the course of the study created an inherent threat to the
rate of referrals.
There are several limitations associated with the current study. One such limitation
includes the small sizes of the participant and medical provider samples. There are currently 14
medical providers at the location where the study was conducted, whose areas of practice span
internal medicine, family medicine, cardiology, rheumatology, orthopedics, endocrinology,
pulmonology, general surgery, gastroenterology, and psychiatry. Due to the small sample sizes,
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there was limited power to detect significant statistically significant results. Unfortunately, small
sample size remains a direct challenge to current standards of design and analytic approaches
(Etz & Arroyo, 2015). With regard to garnishing additional participation from medical providers,
future research should aim to incorporate several ways in which providers may participate in
measures that will add value to the study. For example, it is possible that certain providers prefer
to fill out a paper and pencil survey, rather than utilizing an online modality, which could be
circulated at a monthly provider meeting, in order to increase response rate. As noted previously,
an additional limitation of this study pertains to the difficulties that were present in recruitment
throughout the study. As previous research has indicated the substantial amount of time that has
been required to successfully integrate neuropsychological services into a primary care setting, it
is possible that, with additional time and resources, the slow rate of referrals of the current study
may have resolved. Therefore, future research should aim to have sufficient time in which
aspects related to logistics, referrals, and charting can be fully developed and appropriately
flushed out. Future studies may also include a predetermined method in which new medical
providers are automatically notified of clinic services and the way in which they may refer a
patient through the EMR system. Lastly, the current study is also limited by the lack of diversity
among the patient participants. This inherently limits the extent to which results, particularly
those concerning subjective cognitive decline and objective neurocognitive performance, can be
generalized to other populations. Future research should aim to include a more representative
sample, whose results may generalize more broadly and to culturally diverse populations.
As medical treatment continues to work toward a model that aims to improve the quality
of patient care, while also reducing costs, integration of neuropsychology is increasing. As a
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result, cognitive assessment services have become a part of the growing services that are
accessible within primary care settings (A. Blount et al., 2007; Lanca, 2018). Subsequently, this
has also facilitated recognition that cognitive health is a critical component to overall health and
wellbeing and that detection of cognitive difficulties improves treatment efficacy. The value of
neuropsychology on integrated care teams can be seen in a multitude of capacities.
Neuropsychologists possess a unique expertise, in which their knowledge encompasses
functional neuroanatomy, assessment, and behavior, along with clinical skills that are
fundamental in working with patients (Festa, 2018; Kubu, 2018). Neuropsychologists are able to
address likely barriers to compliance and evaluate cognitive, emotional, behavioral, and
psychosocial facets, all of which contribute to improved patient outcomes (Festa, 2018). The
current study provides additional support for the value of neuropsychological integration into a
primary care setting. Despite a slow referral stream, onsite neurocognitive services allowed for
increased accessibility for both patients and providers and also served as a primary source of
education for patients regarding cognitive symptoms, behavioral components, and subsequent
recommendations. Extant literature indicates that memory disorder clinics are a growing service,
and highlights the importance of neuropsychologists serving in such a role, where they have the
opportunity to deliver these essential services to a patient and, oftentimes, their family. The
current study offers several insights into the complexities associated with both the efficacy and
feasibility of a clinic of this nature.
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APPENDIX A: FIGURES
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23 patients referred for
services
4 patients were unreachable following
multiple contact attempts

19 patients
3 patients declined to receive
services

16 participants enrolled in
and completed the study

Figure 1: Participant Sample Selection
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Patient Participant Satisfaction (n=15)

Strongly
Disagree
1

Satisfied with time spent with me during my visit
My beliefs about my health were considered

Satisfaction Survey Items

I would follow through with outside referral
My cognitive concerns were addressed quickly
Tests and results easy were to understand
I am comfortable receiving services at this clinic
Treated the same as others receiving care here
Prefer cognitive & medical services at same clinic
I was provided with helpful recommendations
Consultation between providers was helpful
Feedack to my physician about cognition was helpful
Overall Satisfaction

Figure 2: Participant Satisfaction Data
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Strongly
Agree
2

3

4

5

Medical Provider Satisfaction

Strongly
Disagree

Satisfaction Survey Items

1

Strongly
Agree
2

3

NP services have been useful in diagnoses
My patients will follow up with NP referrals
My patients can schedule timely NP evals***
Timely reports have been provided*
I can easily gain access to patient's NP reports*
Satisfaction with interaction with np providers**
Results of NP evals have informed my practice
NP evals have facilitated diagnoses
Satisfaction with the NP services available**
Overall Satisfaction*
Pre

Figure 3: Medical Provider Satisfaction Data
Note: *** p≤0.001; ** p≤0.01; * p≤0.05
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Table 1: Participant demographics.

Patient Participants
n = 16
Variable

M (SD)
67.75 (10.47)
17.25 (12.69)
2.38 (1.46)
6.00 (4.47)
4.44 (2.92)

Age
Education (years)
Number of Medical Diagnoses
GAD-7 Total Score
GDS-15 Total Score

Percentage of Sample
Gender
Male
Female
Race
Caucasian
Hispanic/Latino
Partnership Status
Partnered
Unpartnered
Cohabitation Status
Cohabitates
Lives Alone

43.7
56.3
93.8
6.2
75.0
25.0
75.0
25.0

42

Table 2: Bivariate Pearson correlations examining the relationship between subjective cognitive
decline and neurocognitive domains.

Neurocognitive Measure
Trails B
RBANS Delayed Memory Index
RBANS Total Scale Score
Note: n=16.

43

Ecog Total Score
0.02
0.06
0.20

p
0.94
0.84
0.46

Table 3: Partial correlations examining the relationship between subjective cognitive decline and
neurocognitive domains, while controlling for education and GDS-15 scores.

Neurocognitive Measure
Ecog Total Score
p
Trails B
-0.32
0.27
RBANS Delayed Memory Index
0.01
0.99
RBANS Total Scale Score
0.04
0.89
Note: n=16; control variables include years of education and GDS-15 score.
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Table 4: Auxiliary bivariate Pearson correlations examining the relationship between specific
domains of subjective cognitive decline and corresponding neurocognitive performance.

Neurocognitive Domain and Subtest
Language
BNT
COWAT
RBANS Semantic Fluency
Visuospatial
RBANS Figure Copy
RBANS Visuospatial Index Score
Memory
RBANS Delayed Memory Index Score
Executive Function
Trails B
BRBANS Coding
Note: n=16

45

Ecog Domain Score

p

0.09
-0.15
0.28

0.75
0.58
0.30

0.06
0.04

0.82
0.88

0.15

0.59

-0.01
0.29

0.96
0.26

APPENDIX C: PARTICIPANT SCREENING FORM
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SCREENING INFORMATION FOR BRIEF NEUROCOGNITIVE EVALUATION

Patient Name:
Date:

1. Were you born in the United States?

2. If you were born outside of the United States, did you attend high school in the U.S.?

3. What language was primarily spoken in the home while you were growing up?

4. Have you ever received a diagnosis related to your cognitive functioning (i.e., dementia,
Major Neurocognitive Disorder)? If so, is your healthcare proxy here with you?

5. Are you currently involved in any ongoing litigation related to your neurocognitive
functioning, or that involves a previously referred-for neuropsychological assessment?
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APPENDIX D: NEUROCOGNITIVE MEASURES
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COWAT (FAS)

49

NART
Word
CHORD
ACHE
DEPOT
AISLE
BOUQUET
PSALM
CAPON
DENY
NAUSEA
DEBT
COURTEOUS
RAREFY
EQUIVOCAL
NAÏVE
CATACOMB
GAOLED
THYME
HEIR
RADIX
ASSIGNATE
HIATUS
SUBTLE
PROCREATE
GIST
GOUGE
SUPERFLUOUS
SIMILE
BANAL
QUADRUPED
CELLIST

Pronunciation
kɔːd
eɪk
ˈdɛpəʊ
aɪl
buˈkeɪ
sɑːm
ˈkeɪpɒn, ˈkeɪpən
dɪˈnaɪ
ˈnɔːziə, ˈnɔːsiə
det
ˈkɜːtiəs
ˈrɛərɪˌfaɪ
ɪˈkwɪvəkəl), ɪˈkwɪvəkl
naɪˈiːv
ˈkætəˌkəʊm, ˈkætəˌkuːm
dʒeɪld
taɪm
ɛə, eə(r)
ˈreɪdɪks
ˈæsɪɡneɪt
haɪˈeɪtəs
ˈsʌtəl, ˈsʌtl
ˈprəʊkrɪˌeɪt, ˈprəʊkrieɪt
dʒɪst
ɡaʊdʒ
suːˈpɜːflʊəs, suːˈpɜːfluəs, sjuːˈpɜːfluəs
ˈsɪmɪlɪ, ˈsɪməli
bəˈnɑːl
ˈkwɒdrʊˌpɛd, ˈkwɒdruped
ˈtʃelɪst
50

Score
(0/1)

FAÇADE
ZEALOT
DRACHM
AEON
PLACEBO
ABSTEMIOUS
DÉTENTE
IDYLL
PUERPERAL
AVER
GAUCHE
TOPIARY
LEVIATHAN
BEATIFY
PRELATE
SIDEREAL
DEMESNE
SYNCOPE
LABILE
CAMPANILE

fəˈsɑːd, fæˈsɑːd
ˈzɛlət
dræm
ˈiːən, ˈiːɒn
pləˈsiːbəʊ
əbˈstiːmɪəs, əbˈstiːmiəs
deɪˈtɑːnt, French detɑ̃t
ˈɪdɪl
pjuːˈɜːpərəl
əˈvɜː, əˈvɜː(r)
ɡəʊʃ
ˈtəʊpɪərɪ, ˈtəʊpiəri
lɪˈvaɪəθən, ləˈvaɪəθən
bɪˈætɪˌfaɪ, biˈætɪfaɪ
ˈprɛlɪt, ˈprelət
saɪˈdɪərɪəl, saɪˈdɪəriəl
dɪˈmeɪn, dɪˈmiːn, dəˈmeɪn
ˈsɪŋkəpɪ
ˈleɪbɪl
ˌkæmpəˈniːlɪ, ˌkæmpəˈniːli

Total Errors: ______________

Total Errors
0 – 11
12 – 19
20 – 36
37 – 45
46 – 50

Premorbid VIQ Estimate
120 – 129
110 – 119
90 – 109
80 – 89
74 – 79

51

Classification Range
Superior
High Average
Average
Low Average
Borderline

Trails A

52

Trails B

53

Boston Naming Test

54

RBANS

55

56

57

58

59

60

61

62

APPENDIX E: SELF REPORT MEASURES

63

GDS-15

64

GAD-7

65

Ecog

66

67

68

APPENDIX F: PATIENT SATISFACTION SURVEY
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Patient Experience Questionnaire

I am satisfied with the amount of time the
cognitive health specialist spent with me
during my visit.
My beliefs about my health and well-being
were considered as part of the services that I
received.
I would follow through if I were referred
outside this clinic for neuropsychological
testing services.
Any concerns I may have had regarding my
cognitive status were addressed quickly
Testing and results were provided to me in a
language or way I could easily understand.
I am comfortable receiving cognitive health
services here at this clinic.
I am treated the same as other people who get
care at the clinic.
I prefer to receive my cognitive health
services at the location where I receive my
medical care.
I feel I was provided with helpful
recommendations to address my cognitive
concerns.
I feel that consultation between my medical
provider and cognitive health specialist was
helpful to me.
I feel that feedback supplied by my cognitive
health specialist, to my medical provider, was
helpful in coordinating my care.

Strongly
Disagree
1

2

No
Opinion
3

4

Strongly
Agree
5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

How would you rate your overall satisfaction of this service? __________
70

(0 = Not at all satisfied, 10 = Completely satisfied)
Which aspects of the service did you find to be most helpful and why?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

Which aspects of the service did you find to be least helpful and why?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
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Provider Experience Questionnaire

Neuropsychological services that are
available to my patients have been very
useful in determining diagnoses.
My patients will usually follow up when
referred for neuropsychological evaluations.
When referred, my patients have been able to
schedule neuropsychological evaluations in a
timely manner.
The available neuropsychological services
provide timely reports after my patients have
been seen.
Once my patients complete
neuropsychological referrals, I can easily
gain access to their reports.
I am satisfied with the level of interaction
with neuropsychological providers.
Results of neuropsychological evaluations
have helped to inform my practice and
patient care.
Neuropsychological evaluations have
facilitated diagnosis of my patients.
I am satisfied with the neuropsychological
services that have been available to my
patients.

Strongly
Disagree
1

2

No
Opinion
3

4

Strongly
Agree
5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

How would you rate your overall satisfaction of this service? __________
(0 = Not at all satisfied, 10 = Completely satisfied)
Which aspects of neuropsychological services do you find to be most helpful and why?
______________________________________________________________________________
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______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

Which aspects of neuropsychological services do you find to be least helpful and why?
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

Please indicate your current area of practice:
Allergy/Immunology
Cardiology
Dermatology
Endocrinology
Family medicine
Gastroenterology
General surgery
Geriatric medicine
Gynecology
Internal medicine
Nephrology
Ophthalmology
Orthopedics
Psychology
Pulmonology
Rheumatology
Sports Medicine
Other:

74

APPENDIX H: IRB APPROVAL OF HUMAN RESEARCH

75

76

REFERENCES
Agrell, B., & Dehlin, O. (1989). Comparison of six depression rating scales in geriatric stroke
patients. Stroke, 20(9), 1190-1194.
Alegret, M., Rodríguez, O., Espinosa, A., Ortega, G., Sanabria, A., Valero, S., . . . Abdelnour, C.
(2015). Concordance between subjective and objective memory impairment in volunteer
subjects. Journal of Alzheimer's Disease, 48(4), 1109-1117.
Amariglio, R. E., Becker, J. A., Carmasin, J., Wadsworth, L. P., Lorius, N., Sullivan, C., . . .
Sperling, R. A. (2012). Subjective cognitive complaints and amyloid burden in
cognitively normal older individuals. Neuropsychologia, 50(12), 2880-2886.
Anstey, K. J., & Low, L. (2004). Normal cognitive changes in aging. Australian Family
Physician, 33(10), 783-787.
Arnett, P. (2013). Secondary influences on neuropsychological test performance: Oxford
University Press.
Aronow, H. U. (1987). Rehabilitation effectiveness with severe brain injury: translating research
into policy. The Journal of Head Trauma Rehabilitation, 2(3), 24-36.
Balash, Y., Mordechovich, M., Shabtai, H., Giladi, N., Gurevich, T., & Korczyn, A. (2013).
Subjective memory complaints in elders: depression, anxiety, or cognitive decline? Acta
Neurologica Scandinavica, 127(5), 344-350.
Barber, S. J., & Mather, M. (2014). Stereotype threat in older adults: When and why does it
occur, and who is most affected. The Oxford handbook of emotion, social cognition, and
problem solving during adulthood, 302-320.

77

Barth, J. T., Pliskin, N., Axelrod, B., Faust, D., Fisher, J., Harley, J. P., . . . Ricker, J. (2003).
Introduction to the NAN 2001 definition of a clinical neuropsychologist: NAN policy and
planning committee. Archives of Clinical Neuropsychology, 18(5), 551-555.
Block, C. K., Johnson-Greene, D., Pliskin, N., & Boake, C. (2017). Discriminating cognitive
screening and cognitive testing from neuropsychological assessment: implications for
professional practice. The Clinical Neuropsychologist, 31(3), 487-500.
Blount, A. (2003). Integrated primary care: Organizing the evidence. Families Systems and
Health, 21, 121-134.
Blount, A., Schoenbaum, M., Kathol, R., Rollman, B. L., Thomas, M., O'donohue, W., & Peek,
C. (2007). The economics of behavioral health services in medical settings: a summary of
the evidence. Professional Psychology: Research and Practice, 38(3), 290.
Blount, F. A., & Miller, B. F. (2009). Addressing the workforce crisis in integrated primary care.
Journal of Clinical Psychology in Medical Settings, 16(1), 113.
Borson, S., Scanlan, J., Hummel, J., Gibbs, K., Lessig, M., & Zuhr, E. (2007). Implementing
routine cognitive screening of older adults in primary care: process and impact on
physician behavior. Journal of General Internal Medicine, 22(6), 811-817.
Borson, S., Scanlan, J. M., Watanabe, J., Tu, S. P., & Lessig, M. (2006). Improving identification
of cognitive impairment in primary care. International Journal of Geriatric Psychiatry,
21(4), 349-355.
Burmester, B., Leathem, J., & Merrick, P. (2016). Subjective cognitive complaints and objective
cognitive function in aging: a systematic review and meta-analysis of recent crosssectional findings. Neuropsychology Review, 26(4), 376-393.
78

Chen, H., Coakley, E. H., Cheal, K., Maxwell, J., Costantino, G., Krahn, D. D., . . . Zaman, S.
(2006). Satisfaction with mental health services in older primary care patients. The
American Journal of Geriatric Psychiatry, 14(4), 371-379.
Cicerone, K. D., Dahlberg, C., Malec, J. F., Langenbahn, D. M., Felicetti, T., Kneipp, S., . . .
Harley, J. P. (2005). Evidence-based cognitive rehabilitation: updated review of the
literature from 1998 through 2002. Archives of Physical Medicine and Rehabilitation,
86(8), 1681-1692.
Conneeley, A. L. (2012). Transitions and brain injury: a qualitative study exploring the journey
of people with traumatic brain injury. Brain Impairment, 13(1), 72-84.
Craig, W. S. (2015). Integrated Psychological Services in Primary Care. Hauppauge, NY: Nova
Science Pub Inc.
Cullen, B., O’Neill, B., Evans, J. J., Coen, R. F., & Lawlor, B. A. (2007). A review of screening
tests for cognitive impairment. Journal of Neurology, Neurosurgery & Psychiatry, 78(8),
790-799.
De Jager, C. A., & Budge, M. M. (2005). Stability and predictability of the classification of mild
cognitive impairment as assessed by episodic memory test performance over time.
Neurocase, 11(1), 72-79.
Deary, I. J., Corley, J., Gow, A. J., Harris, S. E., Houlihan, L. M., Marioni, R. E., . . . Starr, J. M.
(2009). Age-associated cognitive decline. British Medical Bulletin, 92, 135-152.
doi:10.1093/bmb/ldp033

79

Deary, I. J., & Der, G. (2005). Reaction Time, Age, and Cognitive Ability: Longitudinal
Findings from Age 16 to 63 Years in Representative Population Samples. Aging,
Neuropsychology, and Cognition, 12(2), 187-215. doi:10.1080/13825580590969235
Duff, K., Hobson, V., Beglinger, L., & O'Bryant, S. (2010). Diagnostic Accuracy of the RBANS
in Mild Cognitive Impairment: Limitations on Assessing Milder Impairments. Archives
of Clinical Neuropsychology, 25(5), 429-441.
Ede, V., Okafor, M., Kinuthia, R., Belay, Z., Tewolde, T., Alema-Mensah, E., & Satcher, D.
(2015). An examination of perceptions in integrated care practice. Community Mental
Health Journal, 51(8), 949-961.
Etz, K. E., & Arroyo, J. A. (2015). Small sample research: Considerations beyond statistical
power. Prevention Science, 16(7), 1033-1036.
Farias, S. T., Mungas, D., Reed, B. R., Cahn-Weiner, D., Jagust, W., Baynes, K., & DeCarli, C.
(2008). The measurement of everyday cognition (ECog): scale development and
psychometric properties. Neuropsychology, 22(4), 531.
Farrar, S., Kates, N., Crustolo, A. M., & Nikolaou, L. (2001). Integrated model for mental health
care. Are health care providers satisfied with it? Canadian Family Physician, 47(12),
2483-2488.
Festa, J. R. (2018). Introduction to the Special Issue on Neuropsychology Practices in Integrated
Care Teams. Archives of Clinical Neuropsychology, 33(3), 257-259.
Fowler, N. R., Morrow, L. A., Tu, L.-C., Landsittel, D. P., Snitz, B. E., Rodriquez, E. G., &
Saxton, J. A. (2012). Association between cognitive decline in older adults and use of

80

primary care physician services in Pennsylvania. Journal of Primary Care & Community
Health, 3(3), 201-209.
Ganguli, M., Rodriguez, E., Mulsant, B., Richards, S., Pandav, R., Bilt, J. V., . . . Morycz, R. K.
(2004). Detection and management of cognitive impairment in primary care: The Steel
Valley Seniors Survey. Journal of the American Geriatrics Society, 52(10), 1668-1675.
Goetzel, R. Z., Long, S. R., Ozminkowski, R. J., Hawkins, K., Wang, S., & Lynch, W. (2004).
Health, absence, disability, and presenteeism cost estimates of certain physical and
mental health conditions affecting US employers. Journal of Occupational and
Environmental Medicine, 46(4), 398-412.
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A.,
& Corey-Lisle, P. K. (2003). The economic burden of depression in the United States:
how did it change between 1990 and 2000? Journal of Clinical Psychiatry, 64(12), 14651475.
Harvan, J. R., & Cotter, V. T. (2006). An evaluation of dementia screening in the primary care
setting. Journal of the American Association of Nurse Practitioners, 18(8), 351-360.
Hedrick, S. C., Chaney, E. F., Felker, B., Liu, C. F., Hasenberg, N., Heagerty, P., . . . Paden, G.
(2003). Effectiveness of collaborative care depression treatment in Veterans' Affairs
primary care. Journal of General Internal Medicine, 18(1), 9-16.
Heinemann, A. W., Hamilton, B., Linacre, J. M., Wright, B. D., & Granger, C. (1995).
Functional status and therapeutic intensity during inpatient rehabilitation. American
Journal of Physical Medicine & Rehabilitation, 74(4), 315-326.

81

Hine, J. F., Grennan, A. Q., Menousek, K. M., Robertson, G., Valleley, R. J., & Evans, J. H.
(2017). Physician Satisfaction With Integrated Behavioral Health in Pediatric Primary
Care: Consistency Across Rural and Urban Settings. Journal of Primary Care &
Community Health, 8(2), 89-93.
James, L. C. (2006). Integrating clinical psychology into primary care settings. Journal of
Clinical Psychology, 62(10), 1207-1212.
James, L. C., & O’Donohue, W. T. (2009). The primary care toolkit: a practical resources for
the integrated behavioral care provider: Springer.
Juncos‐Rabadán, O., Pereiro, A. X., Facal, D., Lojo, C., Caamaño, J. A., Sueiro, J., . . . Eiroa,
P. (2014). Prevalence and correlates of mild cognitive impairment in adults aged over 50
years with subjective cognitive complaints in primary care centers. Geriatrics &
Gerontology International, 14(3), 667-673.
Kamminga, J., Bloch, M., Vincent, T., Carberry, A., Brew, B. J., & Cysique, L. A. (2017).
Determining optimal impairment rating methodology for a new HIV-associated
neurocognitive disorder screening procedure. Journal of Clinical and Experimental
Neuropsychology, 1-15.
Kaplan, E., Goodglass, H., & Weintraub, S. (2001). Boston naming test: Pro-ed.
Kates, N., Fugere, C., & Farrar, S. (2004). Family physician satisfaction with mental health
services: Findings from a community survey. Canadian Psychiatric Association Bulletin,
36(2), 10-14.

82

Kieffer, K. M., & Reese, R. J. (2002). A Reliability Generalization Study of the Geriatric
Depression Scale. Educational and Psychological Measurement, 62(6), 969-994.
doi:10.1177/0013164402238085
Kinzer, A., & Suhr, J. A. (2016). Dementia worry and its relationship to dementia exposure,
psychological factors, and subjective memory concerns. Applied Neuropsychology:
Adult, 23(3), 196-204.
Kubu, C. S. (2018). The Role of a Neuropsychologist on a Movement Disorders Deep Brain
Stimulation Team. Archives of Clinical Neuropsychology, 33(3), 365-374.
Kubu, C. S., Ready, R. E., Festa, J. R., Roper, B. L., & Pliskin, N. H. (2016). The Times They
Are a Changin’: Neuropsychology and Integrated Care Teams. The Clinical
Neuropsychologist, 30(1), 51-65.
LaBrie, R. A., LaPlante, D. A., Peller, A. J., Christensen, D. E., Greenwood, K. L., Straus, J. H.,
. . . Shaffer, H. J. (2007). The interdependence of behavioral and somatic health:
implications for conceptualizing health and measuring treatment outcomes. International
Journal of Integrated Care, 7(2).
Lanca, M. (2018). Integration of Neuropsychology in Primary Care. Archives of Clinical
Neuropsychology, 33(3), 269-279.
Lanca, M., & Meisinger, K. (2019). A Model of Collaboration between Primary Care and
Neuropsychology Physician's Field Guide to Neuropsychology (pp. 31-44): Springer.
Larner, A. (2012). Screening utility of the Montreal Cognitive Assessment (MoCA): in place of–
or as well as–the MMSE? International Psychogeriatrics, 24(3), 391-396.
Lezak, M. D. (2004). Neuropsychological assessment: Oxford University Press, USA.
83

Mercury, M. G., Kehoe, R., & Tschan, W. (2007). Neuropsychology for the primary care
physician. Disease-a-month, 53(3), 138-141.
Michels, T. C., Tiu, A. Y., & Graver, C. J. (2010). Neuropsychological evaluation in primary
care. American Family Physician, 82(5), 495-502.
Miller-Matero, L. R., Dubaybo, F., Ziadni, M. S., Feit, R., Kvamme, R., Eshelman, A., &
Keimig, W. (2015). Embedding a psychologist into primary care increases access to
behavioral health services. Journal of Primary Care & Community Health, 6(2), 100-104.
Miller, B. F., Mendenhall, T. J., & Malik, A. D. (2009). Integrated primary care: an inclusive
three-world view through process metrics and empirical discrimination. Journal of
Clinical Psychology in Medical Settings, 16(1), 21-30.
Mills, S. D., Fox, R. S., Malcarne, V. L., Roesch, S. C., Champagne, B. R., & Sadler, G. R.
(2014). The psychometric properties of the Generalized Anxiety Disorder-7 Scale in
Hispanic Americans with English or Spanish language preference. Cultural Diversity and
Ethnic Minority Psychology, 20(3), 463.
Morgan, J. F., & Killoughery, M. (2003). Hospital doctors' management of psychological
problems—Mayou & Smith revisited. The British Journal of Psychiatry, 182(2), 153157.
Morris, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., . . . Clark,
C. (1989). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD).
Part I. Neurology, 39, 1159-1165.
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., . . .
Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool
84

for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695699.
Park, D. C., Polk, T. A., Mikels, J. A., Taylor, S. F., & Marshuetz, C. (2001). Cerebral aging:
integration of brain and behavioral models of cognitive function. Dialogues In Clinical
Neuroscience, 3(3), 151-165.
Peek, C. (2013). Lexicon for Behavioral Health and Primary Care Integration. Rockville, MD:
Agency for Healthcare Research and Quality.
Peikes, D., Zutshi, A., Genevro, J. L., Parchman, M. L., & Meyers, D. S. (2012). Early
evaluations of the medical home: building on a promising start. American Journal of
Managed Care, 18(2), 105.
Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., & Rahman, A. (2007).
No health without mental health. The Lancet, 370(9590), 859-877.
Rabin, L. A., Smart, C. M., Crane, P. K., Amariglio, R. E., Berman, L. M., Boada, M., . . . Ellis,
K. A. (2015). Subjective cognitive decline in older adults: an overview of self-report
measures used across 19 international research studies. Journal of Alzheimer's Disease,
48(s1), S63-S86.
Randolph, C. (1998). RBANS Manual—Repeatable Battery for the Assessment of
Neuropsychological Status. San Antonio, TX: Psychological Corp (Harcourt).
Rattanabannakit, C., Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., . . .
Farlow, M. R. (2016). The Cognitive Change Index as a measure of self and informant
perception of cognitive decline: relation to neuropsychological tests. Journal of
Alzheimer's Disease, 51(4), 1145-1155.
85

Raz, N., Lindenberger, U., Rodrigue, K. M., Kennedy, K. M., Head, D., Williamson, A., . . .
Acker, J. D. (2005). Regional brain changes in aging healthy adults: general trends,
individual differences and modifiers. Cereb Cortex, 15(11), 1676-1689.
doi:10.1093/cercor/bhi044
Reitan, R. M. (1958). Validity of the trail making test as ain indicator of organic brain damage.
Perceptual and Motor Skills, 8, 271-276.
Roy-Byrne, P. P., & Wagner, A. (2004). Primary care perspectives on generalized anxiety
disorder. The Journal of Clinical Psychiatry, 65, 20-26.
Ruchinskas, R. A., & Cullum, C. M. (2018). Neuropsychology in a Memory Disorder Clinic.
Archives of Clinical Neuropsychology, 33(3), 301-309. doi:10.1093/arclin/acx128
Salthouse, T. A. (2009). When does age-related cognitive decline begin? Neurobiology of Aging,
30(4), 507-514. doi:10.1016/j.neurobiolaging.2008.09.023
Salthouse, T. A. (2012). Does the level at which cognitive change occurs change with age?
Psychological Science, 23(1), 18-23. doi:10.1177/0956797611421615
Sheikh, J. I., & Yesavage, J. A. (1986). Geriatric depression scale (GDS) recent evidence and
development of a shorter version. Clinical Gerontologist, 5, 165-173.
Shulman, K. I., Herrmann, N., Brodaty, H., Chiu, H., Lawlor, B., Ritchie, K., & Scanlan, J. M.
(2006). IPA survey of brief cognitive screening instruments. International
Psychogeriatrics, 18(2), 281-294.
Snitz, B. E., Morrow, L. A., Rodriguez, E. G., Huber, K. A., & Saxton, J. A. (2008). Subjective
memory complaints and concurrent memory performance in older patients of primary

86

care providers. Journal of the International Neuropsychological Society, 14(6), 10041013.
Spreen, O., & Risser, A. H. (2003). Assessment of aphasia: Oxford University Press.
Stephens, J. A., Williamson, K.-N. C., & Berryhill, M. E. (2015). Cognitive rehabilitation after
traumatic brain injury: a reference for occupational therapists. OTJR: Occupation,
Participation and Health, 35(1), 5-22.
Suhr, J. A., & Kinkela, J. H. (2007). Perceived threat of Alzheimer disease (AD): the role of
personal experience with AD. Alzheimer Disease & Associated Disorders, 21(3), 225231.
Tabachnick, B. G., & Fidell, L. S. (2013). Using multivariate statistics. Upper Saddle River, NJ:
Pearson.
Temple, R. O., Carvalho, J., & Tremont, G. (2006). A national survey of physicians’ use of and
satisfaction with neuropsychological services. Archives of Clinical Neuropsychology,
21(5), 371-382.
Thompson, C. L., Henry, J. D., Rendell, P. G., Withall, A., & Brodaty, H. (2015). How valid are
subjective ratings of prospective memory in mild cognitive impairment and early
dementia? Gerontology, 61(3), 251-257.
Trzepacz, P. T., Hochstetler, H., Wang, S., Walker, B., & Saykin, A. J. (2015). Relationship
between the Montreal Cognitive Assessment and Mini-mental State Examination for
assessment of mild cognitive impairment in older adults. BMC Geriatrics, 15(1), 107.
Uttl, B. (2002). North American Adult Reading Test: Age norms, reliability, and validity.
Journal of Clinical and Experimental Neuropsychology, 24(8), 1123-1137.
87

Vogel, M. E., Kanzler, K. E., Aikens, J. E., & Goodie, J. L. (2017). Integration of behavioral
health and primary care: current knowledge and future directions. Journal of Behavioral
Medicine, 40(1), 69-84.
Weintraub, D., Saboe, K., & Stern, M. B. (2007). Effect of age on geriatric depression scale
performance in Parkinson's disease. Movement Disorders, 22(9), 1331-1335.
Welsh-Bohmer, K., & Mohs, R. C. (1997). Neuropsychological assessment of Alzheimer's
disease. Neurology, 49(3), 11-13.
Wolfs, C. A., Dirksen, C. D., Kessels, A., Severens, J. L., & Verhey, F. R. (2009). Economic
evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a
randomized controlled trial. Archives of General Psychiatry, 66(3), 313-323.
Zeiss, A. M., & Karlin, B. E. (2008). Integrating mental health and primary care services in the
Department of Veterans Affairs health care system. Journal of Clinical Psychology in
Medical Settings, 15(1), 73-78.
Zlatar, Z. Z., Moore, R. C., Palmer, B. W., Thompson, W. K., & Jeste, D. V. (2014). Cognitive
complaints correlate with depression rather than concurrent objective cognitive
impairment in the successful aging evaluation baseline sample. Journal of Geriatric
Psychiatry and Neurology, 27(3), 181-187.
Zlatar, Z. Z., Muniz, M., Galasko, D., & Salmon, D. P. (2017). Subjective cognitive decline
correlates with depression symptoms and not with concurrent objective cognition in a
clinic-based sample of older adults. The Journals of Gerontology: Series B, 73(7), 11981202.

88

